BrightSpring Health Services, Inc. (BTSG) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds opening new positions and 2 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $874.4K sold). Latest close $68.34 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 14, 2026 · Congress to Nov 16, 2026.
Alta Fox Capital Management · Viking Global Investors · Axiom Investors — 3 tracked funds hold BTSG. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 1 sale ($874.4K). Insider trading
Aveanna Healthcare Holdings, Inc. (AVAH) · Option Care Health, Inc. (OPCH) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Alta Fox Capital Management | 13.70% | 977,000 | TRIMMED (-31.4%) Q3 filed Nov 16 |
| Viking Global Investors | 0.32% | 1,618,237 | NEW Q3 filed Nov 16 |
| Axiom Investors | 0.16% | 259,867 | NEW Q3 filed Nov 12 |
| OrbiMed Advisors | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: 0.0% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 421 of 8,857 filers |
| Long-only filers among them | 419 |
| Change vs 2026 Q1 | +93 net · 400 entered · 307 exited |
| Shares reported, all filers | 207,621,515 |
| Reported value, all filers | $13.1B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Services-Home Health Care Services (SIC 8082) |
| Revenue · FY2025 | $12.9B |
| Net income · FY2025 | $190.7M |
| Total assets · FY2025 | $6.4B |
| Shares outstanding | 197,864,241 |
| Market cap (at latest close) | $13.5B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 28, 2026.
| Shares short · Oct 15, 2026 | 11,473,131 |
| Share of shares outstanding | 5.80% |
| Days to cover | 5.18 |
Shares short at recent settlements — Jul 31, 2026: 8.4M · Aug 14, 2026: 8.8M · Aug 31, 2026: 10.1M · Sep 15, 2026: 10.2M · Sep 30, 2026: 12.0M · Oct 15, 2026: 11.5M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 28, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 28, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($874.4K).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Greenwell Scott A. | President, PharMerica | Sell | 15,099 | $57.91 | $874.4K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Greenwell Scott A. | Officer | 15,099 | $874.4K | Sep 14, 2026 | SEC filing |
| Jun 3, 2026 | Barnes Robert Allen | Former Officer | 62,608 | $3.8M | Jun 3, 2026 | SEC filing |
| Jun 2, 2026 | Barnes Robert Allen | Former Officer | 9,201 | $551.6K | Jun 2, 2026 | SEC filing |
| Aug 14, 2025 | McMaude Michael A | Former Officer | 16,168 | $362.2K | Aug 14, 2025 | SEC filing |
| Feb 18, 2025 | Walgreen Co. | 10% Stockholder | 12,000,000 | $265.8M | Feb 18, 2025 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Jun 5, 2026 | SCHEDULE 13D/A | +17.9% (close Jun 8, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Jun 8, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | FMR LLC | SC 13G/A | 13,678,154.97 | 7.0% | Jun 30, 2026 | SEC filing |
| Jul 31, 2026 | Vanguard Portfolio Management | SC 13G | 10,105,607 | 5.2% | Jun 30, 2026 | SEC filing |
| Jul 27, 2026 | BlackRock, Inc. | SC 13G/A | 23,745,051 | 12.0% | Jun 30, 2026 | SEC filing |
| Jun 5, 2026 | KKR Phoenix Aggregator L.P. | SC 13D/A | 26,829,880 | 13.6% | Jun 3, 2026 | SEC filing |
| May 6, 2026 | FMR LLC | SC 13G/A | 21,200,804.91 | 10.9% | Mar 31, 2026 | SEC filing |
| Apr 7, 2026 | BlackRock, Inc. | SC 13G/A | 20,564,901 | 10.6% | Mar 31, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Mar 4, 2026 | KKR Phoenix Aggregator L.P. | SC 13D/A | 41,824,259 | 21.7% | Mar 2, 2026 | SEC filing |
| Feb 5, 2026 | FMR LLC | SC 13G/A | 22,912,232.08 | 12.7% | Dec 31, 2025 | SEC filing |
| Jan 30, 2026 | The Vanguard Group | SC 13G/A | 12,533,656 | 6.9% | Dec 31, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Services-Home Health Care Services (SIC 8082). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 56 Lobbying Disclosure Act filings named this company as client, 2017–2026; most common issues: Medicare/Medicaid (51), Labor Issues/Antitrust/Workplace (29), Health Issues (25).
Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Financial Screens
· Piotroski — Financial health improved over the past year
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Key figures
· Piotroski — F-score: 7 · Return on assets: 3.0% · Operating cash flow: $490.2M
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2024 Q3, ranked #34 of 50.
Also held by the tracked funds that hold BTSG — ranked by lift, the co-holding pattern described in Methodology: Aveanna Healthcare Holdings, Inc. (AVAH) · Option Care Health, Inc. (OPCH) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · Brookdale Senior Living Inc. (BKD) · Acadia Healthcare Company, Inc. (ACHC) · LABCORP HOLDINGS INC. (LH).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 30, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Jul 31, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Jun 12, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Aveanna Healthcare Holdings, Inc. (AVAH) · Track Record: how the signals scored · Practice timing on BTSG
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.